Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Paolo Mora is a specialized healthcare provider and clinical research entity based in Parma, Italy, led by Dr. Paolo Mora, an Associate Professor of Ophthalmology at the University of Parma. The practice focuses on the diagnosis and surgical management of complex vitreoretinal diseases, including retinal detachment, macular holes, and diabetic retinopathy, as well as inflammatory conditions such as uveitis. In addition to providing high-level clinical care, the entity serves as a significant site for international clinical trials, collaborating with pharmaceutical companies to evaluate novel therapies for ocular pathologies. Dr. Mora's work integrates academic research with clinical practice, contributing to the development of advanced treatment protocols in ophthalmology. The entity is primarily recognized for its expertise in medical retina and vitreoretinal surgery within the European healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DR. PAOLO MORA.